miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6579-6588

  Zhou, Qihui ^a   Haupt, Sonja ^a   Prots, Iryna ^a,d   Thümmler, Katja ^a,e   Kremmer, Elisabeth ^b   Lipsky, Peter E ^c   Schulze Koops, Hendrik ^a   Skapenko, Alla ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN A REPETITIONS PREDOMINANT; MESSENGER RNA; MICRORNA; MICRORNA 142 3P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; GENE INTERACTION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA BINDING; RNA DEGRADATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; RATS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84879122502     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202993     Document Type: Article

References (38)

1. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Kulshreshtha, R., M. Ferracin, M. Negrini, G. A. Calin, R. V. Davuluri, and M. Ivan. 2007. Regulation of microRNA expression: the hypoxic component. Cell Cycle 6: 1426-1431.
3. Bartel, D. P., and C. Z. Chen. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5: 396-400. (Pubitemid 38529411)
4. Bernstein, E., S. Y. Kim, M. A. Carmell, E. P. Murchison, H. Alcorn, M. Z. Li, A. A. Mills, S. J. Elledge, K. V. Anderson, and G. J. Hannon. 2003. Dicer is essential for mouse development. Nat. Genet. 35: 215-217. (Pubitemid 37363172)
5. Bushati, N., and S. M. Cohen. 2007. MicroRNA functions. Annu. Rev. Cell Dev. Biol. 23: 175-205.
6. Lindsay, M. A. 2008. MicroRNAs and the immune response. Trends Immunol. 29: 343-351.
7. Cobb, B. S., T. B. Nesterova, E. Thompson, A. Hertweck, E. O'Connor, J. Godwin, C. B. Wilson, N. Brockdorff, A. G. Fisher, S. T. Smale, and M. Merkenschlager. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201: 1367-1373. (Pubitemid 40664081)
8. Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269. (Pubitemid 41043822)
9. Koralov, S. B., S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty, C. Kanellopoulou, K. Jensen, B. S. Cobb, M. Merkenschlager, N. Rajewsky, and K. Rajewsky. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874. (Pubitemid 351312808)
10. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161. (Pubitemid 46507589)
11. Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, and K. Rajewsky. 2007. miR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159. (Pubitemid 47498525)
12. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608. (Pubitemid 46683147)
13. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611. (Pubitemid 46683148)
14. Stittrich, A. B., C. Haftmann, E. Sgouroudis, A. A. Kühl, A. N. Hegazy, I. Panse, R. Riedel, M. Flossdorf, J. Dong, F. Fuhrmann, et al. 2010. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 11: 1057-1062.
15. Cobb, B. S., A. Hertweck, J. Smith, E. O'Connor, D. Graf, T. Cook, S. T. Smale, S. Sakaguchi, F. J. Livesey, A. G. Fisher, and M. Merkenschlager. 2006. A role for Dicer in immune regulation. J. Exp. Med. 203: 2519-2527. (Pubitemid 44664621)
16. Liston, A., L. F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205: 1993-2004.
17. Kobe, B., and A. V. Kajava. 2001. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11: 725-732. (Pubitemid 34076634)
18. Wang, R., Q. Wan, L. Kozhaya, H. Fujii, and D. Unutmaz. 2008. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE 3: e2705.
19. Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
20. Tran, D. Q., J. Andersson, R. Wang, H. Ramsey, D. Unutmaz, and E. M. Shevach. 2009. GARP (LRRC32) is essential for the surface expression of latent TGF-b on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 13445-13450.
21. Stockis, J., D. Colau, P. G. Coulie, and S. Lucas. 2009. Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur. J. Immunol. 39: 3315-3322.
22. Liu, C. J., S. C. Lin, Y. J. Chen, K. M. Chang, and K. W. Chang. 2006. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol. Carcinog. 45: 721-731.
23. Martinez-Cardús, A., E. Martinez-Balibrea, E. Bandrés, R. Malumbres, A. Ginés, J. L. Manzano, M. Taron, J. Garcia-Foncillas, and A. Abad. 2009. Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer. Mol. Cancer Ther. 8: 194-202.
24. Lassmann, S., R. Weis, F. Makowiec, J. Roth, M. Danciu, U. Hopt, and M. Werner. 2007. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med.(Berl.) 85: 293-304.
25. Bekri, S., J. Adélaïde, S. Merscher, J. Grosgeorge, F. Caroli-Bosc, D. Perucca-Lostanlen, P. M. Kelley, M. J. Pébusque, C. Theillet, D. Birnbaum, and P. Gaudray. 1997. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet. Cell Genet. 79: 125-131. (Pubitemid 28107833)
26. Rodriguez, C., L. Hughes-Davies, H. Vallès, B. Orsetti, M. Cuny, L. Ursule, T. Kouzarides, and C. Theillet. 2004. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome. Clin. Cancer Res. 10: 5785-5791. (Pubitemid 39180956)
27. Maire, G., A. Forus, C. Foa, B. Bjerkehagen, C. Mainguené, S. H. Kresse, O. Myklebost, and F. Pedeutour. 2003. 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer 37: 389-395. (Pubitemid 36775781)
28. Schraml, P., G. Schwerdtfeger, F. Burkhalter, A. Raggi, D. Schmidt, T. Ruffalo, W. King, K. Wilber, M. J. Mihatsch, and H. Moch. 2003. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am. J. Pathol. 163: 985-992. (Pubitemid 37040134)
29. Edwards, J., N. S. Krishna, C. J. Witton, and J. M. Bartlett. 2003. Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin. Cancer Res. 9: 5271-5281. (Pubitemid 37413579)
30. Beitzinger, M., and G. Meister. 2011. Experimental identification of microRNA targets by immunoprecipitation of Argonaute protein complexes. Methods Mol. Biol. 732: 153-167.
31. + TREG cells by targeting AC9 mRNA. EMBO Rep. 10: 180-185.
32. Meister, G., M. Landthaler, A. Patkaniowska, Y. Dorsett, G. Teng, and T. Tuschl. 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15: 185-197. (Pubitemid 38950966)
33. Stark, A., J. Brennecke, N. Bushati, R. B. Russell, and S. M. Cohen. 2005. Animal microRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146. (Pubitemid 41785426)
34. Cohen, S. M., J. Brennecke, and A. Stark. 2006. Denoising feedback loops by thresholding: a new role for microRNAs. Genes Dev. 20: 2769-2772. (Pubitemid 44771738)
35. Kedde, M., M. J. Strasser, B. Boldajipour, J. A. Oude Vrielink, K. Slanchev, C. le Sage, R. Nagel, P. M. Voorhoeve, J. van Duijse, U. A. Ørom, et al. 2007. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131: 1273-1286.
36. Kedde, M., M. van Kouwenhove, W. Zwart, J. A. Oude Vrielink, R. Elkon, and R. Agami. 2010. A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nat. Cell Biol. 12: 1014-1020.
37. Yu, D., A. H. Tan, X. Hu, V. Athanasopoulos, N. Simpson, D. G. Silva, A. Hutloff, K. M. Giles, P. J. Leedman, K. P. Lam, et al. 2007. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450: 299-303. (Pubitemid 350100535)
38. Bhattacharyya, S. N., R. Habermacher, U. Martine, E. I. Closs, and W. Filipowicz. 2006. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125: 1111-1124. (Pubitemid 43866197)